9-114155957-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032888.4(COL27A1):c.7G>A(p.Ala3Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,278,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032888.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL27A1 | NM_032888.4 | c.7G>A | p.Ala3Thr | missense_variant | 1/61 | ENST00000356083.8 | NP_116277.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL27A1 | ENST00000356083.8 | c.7G>A | p.Ala3Thr | missense_variant | 1/61 | 1 | NM_032888.4 | ENSP00000348385 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151102Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000704 AC: 5AN: 71032Hom.: 0 AF XY: 0.0000735 AC XY: 3AN XY: 40792
GnomAD4 exome AF: 0.000135 AC: 152AN: 1127602Hom.: 0 Cov.: 31 AF XY: 0.000126 AC XY: 68AN XY: 538650
GnomAD4 genome AF: 0.000152 AC: 23AN: 151210Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 10AN XY: 73936
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 17, 2023 | The c.7G>A (p.A3T) alteration is located in exon 1 (coding exon 1) of the COL27A1 gene. This alteration results from a G to A substitution at nucleotide position 7, causing the alanine (A) at amino acid position 3 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2021 | This sequence change replaces alanine with threonine at codon 3 of the COL27A1 protein (p.Ala3Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. This variant is present in population databases (rs538968859, ExAC 0.08%). This variant has not been reported in the literature in individuals affected with COL27A1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at